EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire

Junfen Zhang iD, Aviël Ragamin iD, Geertruida L E Romeijn iD, Laura Loman iD, Jart A F Oosterhaven iD, Marie L A Schuttelaar iD

British Journal of Dermatology · 25.10.2023 · 189 (5) · 578-587

DOI: 10.1093/bjd/ljad247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 18.07.2023. Verfasst von Junfen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Groningen, University Medical Center Groningen, the Netherlands. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Eczema. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited research has been conducted on the measurement properties of the Recap of atopic eczema (RECAP) questionnaire, particularly in relation to interpretability.

Objectives

To investigate the validity, reliability, responsiveness and interpretability of the Dutch RECAP in adults with atopic dermatitis (AD).

Methods

We conducted a prospective study in a Dutch tertiary hospital, recruiting adults with AD between June 2021 and December 2022. Patients completed the RECAP questionnaire, reference instruments and anchor questions at the following three timepoints: baseline, after 1–3 days and after 4–12 weeks. Hypotheses testing was used to investigate single-score validity and change-score validity (responsiveness). To assess reliability, both standard error of measurement (SEMagreement) and intraclass correlation coefficient (ICCagreement) were reported. To assess the interpretability of single scores, bands for eczema control were proposed. To investigate the interpretability of change scores, both smallest detectable change (SDC) and minimally important change (MIC) scores were determined. To estimate the MIC scores, four different anchor-based methods were employed: the mean change method, 95% limit cut-off point, receiver operating characteristic curve and predictive modelling.

Results

In total, 200 participants were included (57.5% male sex, mean age 38.5 years). Of the a priori hypotheses, 82% (single-score validity) and 59% (responsiveness) were confirmed. Known-group analyses showed differences in the RECAP scores between patient groups based on disease severity and impairment of the quality of life. The SEMagreement was 1.17 points and the ICCagreement was 0.988. The final banding was as follows: 0–1 (completely controlled); 2–5 (mostly controlled); 6–11 (moderately controlled); 12–19 (a little controlled); 20–28 (not at all controlled). Moreover, a single cut-off point of ≥ 6 was determined to identify patients whose AD is not under control. The SDC was 3.2 points, and the MIC value from the predictive modelling was 3.9 points. Neither floor nor ceiling effects were observed.

Conclusions

The RECAP has good single-score validity, moderate responsiveness and excellent reliability. This study fills a gap in the interpretability of the RECAP. Our results indicate a threshold of ≥ 6 points to identify patients whose AD is ‘not under control’, while an improvement of ≥ 4 points represents a clinically important change. Given its endorsement by the Harmonising Outcome Measures for Eczema initiatives, the results of this study support the integration of RECAP into both routine clinical practice and research settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicEczemaAdultHumansMaleFemaleQuality of LifeProspective StudiesReproducibility of ResultsSurveys and Questionnaires

Autor:innen und Institutionen

  • Department of Dermatology, University of Groningen, University Medical Center Groningen, the Netherlands.
  • Department of Dermatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.

ORCID-Profile: Junfen Zhang, Aviël Ragamin, Geertruida L E Romeijn, Laura Loman, Jart A F Oosterhaven, Marie L A Schuttelaar

Förderung

  • China Scholarship Council

Zitieren

APA

Zhang, J., Ragamin, A., Romeijn, G. L. E., Loman, L., Oosterhaven, J. A. F., & Schuttelaar, M. L. A. (2023). Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire. British Journal of Dermatology, 189(5), 578-587. https://doi.org/10.1093/bjd/ljad247

Vancouver

Zhang J, Ragamin A, Romeijn GLE, Loman L, Oosterhaven JAF, Schuttelaar MLA. Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire. British Journal of Dermatology. 2023;189(5):578-587. doi:10.1093/bjd/ljad247

BibTeX
@article{Zhang2023,
  author = {Zhang, Junfen and Ragamin, Aviël and Romeijn, Geertruida L E and Loman, Laura and Oosterhaven, Jart A F and Schuttelaar, Marie L A},
  title = {Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire},
  journal = {British Journal of Dermatology},
  year = {2023},
  volume = {189},
  number = {5},
  pages = {578--587},
  doi = {10.1093/bjd/ljad247}
}
Kostenlos starten →